Atento Capital
VC Fund
Tulsa, United States
Atento Capital is a Tulsa-based investment firm focused on returns, quality job creation, and being helpful. They look for exceptional entrepreneurs that address large markets. Most of their investments will be in early-stage venture funds from other parts of the country and world. They look for funds with cumulative advantages in their investmentspace that can drive outsized returns, but also those who will be willing partners in their effort to build a tech ecosystem in the city of Tulsa.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 35%
Last updated:
For AI agents: llms.txt
Industries Atento Capital invests in
Stages Atento Capital invests in
Countries Atento Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $1.4M–$5.4M
- Pre-Seed
- $350k–$2M
- Series A
- $4.5M–$60M
Investment Focus
Industry
- Software 11 (30%)
- Health Care 9 (24%)
- Medical 5 (14%)
- SaaS 3 (8%)
- Family 2 (5%)
Stage
- Seed 11 (30%)
- Pre-Seed 10 (27%)
- Series A 8 (22%)
- Series B 3 (8%)
- Series C 1 (3%)
Country
- United States 22 (59%)
- Chile 1 (3%)
- Israel 1 (3%)
- Argentina 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Josephine Nelms
Director of Operations
|
Director of Operations | Total investments: 0 | Find email | |
|
Lawrence Watkins
Head of Strategic Partnerships
|
Head of Strategic Partnerships | Total investments: 1 | Find email | |
|
Michael Basch
Founder, Chief Executive Officer, General Partner
|
Founder, Chief Executive Officer, General Partner | Total investments: 6 | Find email | |
|
Will Gray
Head of Investments
|
Head of Investments | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
We use insects to process organic waste in modular units called bioreactors and offer this technology as a waste management service. This modular infrastructure allows us to integrate our units into the existing waste infrastructure of our clients and, at their facilities, convert their waste into high-value and low-impact protein, fertilizer and,because we have a carbon negative process, carbon bonds. | $1.4M / Seed / Jul 07, 2024 | |
|
|
Respond Flow is a text marketing platform that fully manages compliance, empowering organizations to confidently connect with their audiences while following regulations, avoiding fines, and protecting brand reputations. | $3M / Seed / Apr 23, 2024 | |
|
|
Florence is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff. | $60M / Series A / Feb 21, 2024 | |
|
|
Bioeutectics is making industrial products and processes more environmentally friendly by supplying high-performance, natural, and long-lasting solvents. Bioeutectics mimics the way plants create their own solvents utilizing 100% renewable resources using eutectic technology. The company replaces petrochemical solvents used in industrial processesthat have previously been used. By producing green eutectic solvents, they controlled the market with natural alternatives. | $2.1M / Seed / Jan 22, 2024 | |
|
|
Optimize.health is a provider of a digital healthcare platform that enables the deployment of Remote Patient Monitoring (RPM) programs.It uses easy-to-use equipment and software. The software is designed to facilitate provider compliance when billing to new Medicare CPT codes for RPM while providing a great user experience for both patients andproviders. Its system is designed to be profitable for physicians starting in the first month.Chuks Onwuneme, Jeff LeBrun, and Otto Sipe established the company in Seattle, Washington in 2015. | $18M / Series B / Sep 30, 2023 | |
|
|
PatchRx is a remote therapeutic management platform that boosts adherence and helps increase patient compliance. PatchRx's 360-degree approach to medication compliance is designed to assist clinics in capitalizing on remote therapeutic monitoring. PatchRx uses data-driven technology to improve prescription adherence and assist users inremembering to take their medication. The service, which consists of a universal smart pill bottle device, a patient-facing app, and a web app, assists patients in taking their medications on time, allows refills, rewards patients for good adherence, and streamlines true adherence data back to care providers. | $8M / Series A / Aug 30, 2023 | |
|
|
Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs. | $67M / Series C / Jun 12, 2023 | |
|
|
Pear Suite is a digital health company that helps community health workers to address social determinants of health through culturally sensitive care navigation.. The cloud-based platform of Pear Suite enables anyone to better assess and address social determinants of health in a scalable, cost-effective, and person-centered manner. Its platform,unlike other assessment tools, enables anyone to assess and address an individual's social drivers of health through smart scripts, logic modeling, and actionable dashboards. | $2.5M / Seed / May 15, 2023 | |
|
|
Ox is an enterprise software provider that develops human-centered automation systems across the supply chain. The Operator Experience directs frontline operators to perform their work through software automation, wearable displays, and artificial intelligence to deliver operational excellence. | $12.6M / Series A / Apr 24, 2023 | |
|
|
SquadTrip is a SaaS platform that makes booking and payments easy for group trips. The platform allows users to save time managing group travel by creating beautiful trip sites, automating guest billing, and keeping track of all traveler logistics from one place. | $1.5M / Seed / Apr 13, 2023 | |
| See all 37 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Atento Capital invest in?
Atento Capital invests primarily in Software, Health Care and Medical startups, most often at Seed and Pre-Seed stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Atento Capital's check size?
Atento Capital typically joins rounds of $1.4M–$5.4M at Seed, $350k–$2M at Pre-Seed and $4.5M–$60M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Atento Capital participates in.
How do I contact Atento Capital?
Public channels for Atento Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Atento Capital?
The team at Atento Capital includes Josephine Nelms (Director of Operations), Lawrence Watkins (Head of Strategic Partnerships) and Michael Basch (Founder, Chief Executive Officer, General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!